Navigation Links
Tracheolife II HME

ProductsTracheolife II HME
Company Nellcor
Item Tracheolife II HME
Features 
  • Single use device, complete with oxygen port positioned to allow heating and humidification of all inspired gases.
  • Collection chamber ensures functionality is not compromised in the presence of sputum.
  • Easy replacement without additional assembly.
  • Easy and non-traumatic replacement.
  • High humidification efficiency.
  • No further components required.
  • Central port allows suctioning and sampling to be performed without removing the HME.
  • ISO standard 15mm fitting.
  • Supplied clean and individually packaged.
Description Indications For Usage:

Single use on tracheostomy patients who can breathe spontaneously. The product is intended to be replaced at least once every 24 hours.
Info Nellcor
Customer Service: (800) 635-5267
Web site: http://www.nellcor.com/

Related medicine products :

1. Bivona® Fome-Cuf® Wire Reinforced Endotracheal Tube Kits
2. Bivona® Intubation Stylet - Large
3. Bivona® Intubation Stylet - Small
4. Bivona® Fixed-Flange Hyperflex™ Extra Length Tracheostomy Tubes
5. Bivona® Mid-Range Aire-Cuf® Adjustable Neck Flange Hyperflex™ Tracheostomy Tubes
6. Bivona® TTS™ Adjustable Neck Flange Hyperflex™ Tracheostomy Tubes
7. Bivona® Uncuffed Adult Tracheostomy Tubes
8. Bivona® Mid-Range Aire-Cuf® Tracheostomy Tubes
9. Bivona® TTS™ Tracheostomy Tubes
10. Bivona® Laryngectomy Tubes
11. Bivona® Mid-Range Aire-Cuf® and Fome-Cuf® Tracheostomy Tubes with Talk Attachment
Other Medicine News:Health News:Prime Healthcare Services to Acquire Three Hospitals from Tenet Healthcare Corporation 2Health News:Meetings with Pre-Screened Verified China Suppliers Help 14 Top Buyers, Including Brookstone and Staples, Save Time and Cut Sourcing Costs 2Health News:Meetings with Pre-Screened Verified China Suppliers Help 14 Top Buyers, Including Brookstone and Staples, Save Time and Cut Sourcing Costs 3Health News:Meetings with Pre-Screened Verified China Suppliers Help 14 Top Buyers, Including Brookstone and Staples, Save Time and Cut Sourcing Costs 4Health News:More girls than boys benefit from breastfeeding, Hopkins Children's research shows 2Health News:More girls than boys benefit from breastfeeding, Hopkins Children's research shows 3Health News:Bunk beds pose dangers to kids and adults 2Health News:Bunk beds pose dangers to kids and adults 3Health News:Large study identifies most costly adverse events in children's hospitals 2Health News:First study to examine vitamin D insufficiency in pediatric patients with low bone density 2
Breaking Medicine Technology:Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 1Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 2Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 3Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 4Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 5Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 6Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 7Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 8Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 9Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 10Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 11ULURU Inc to Present Altrazeal 28TM 29 Clinical Evidence at the American Podiatric Medical Association 28APMA 29 Annual Scientific Meeting in Toront 53161 1ULURU Inc to Present Altrazeal 28TM 29 Clinical Evidence at the American Podiatric Medical Association 28APMA 29 Annual Scientific Meeting in Toront 53161 2ULURU Inc to Present Altrazeal 28TM 29 Clinical Evidence at the American Podiatric Medical Association 28APMA 29 Annual Scientific Meeting in Toront 53161 3Regence Wins Awards for Consumer Appeal to Transform Health Care 53156 1Regence Wins Awards for Consumer Appeal to Transform Health Care 53156 2